Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06989086 · ClinicalTrials.gov registry record · NA

FearLess in NeuroOncology

A NA study of Caregiver and Astrocytoma, sponsored by Virginia Commonwealth University.

Recruiting
Registry status
NA
Development phase
112
Enrollment target
1
Study location

NCT06989086 is a NA study of Caregiver and Astrocytoma that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 112 participants, below the 1,251-participant average among 20 other Caregiver trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06989086, a NA study of Caregiver and Astrocytoma, is actively recruiting participants, sponsored by Virginia Commonwealth University.

RECRUITING
Registry status
NA
Development phase
112 participants
Enrollment target
1
Study location

Study Summary

The overarching goal of this project is to assess the feasibility, acceptability, and appropriateness of recruitment methods, target population, and a waitlist design to finalize the protocol of FearLess in primary malignant brain tumor patients and caregivers

Interventions

  • BEHAVIORAL Fearless in Neuro-Oncology

Study Locations (1)

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2025-06-24
Est. Completion 2028-12-31
Phase NA

Sponsor

Virginia Commonwealth University

558 total trials

What the Registry Record Tells You About NCT06989086

The ClinicalTrials.gov registry entry for NCT06989086 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,251-participant average among 20 other Caregiver trials with a reported enrollment target (91% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Caregiver appearing as the primary indexed condition, and to 1 intervention - of which Fearless in Neuro-Oncology is the first listed.

NCT06989086 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT06989086 about?

NCT06989086 is a clinical study titled "FearLess in NeuroOncology". The overarching goal of this project is to assess the feasibility, acceptability, and appropriateness of recruitment methods, target population, and a waitlist design to finalize the protocol of FearLess in primary malignant brain tumor patients and caregivers

What is the current status of trial NCT06989086?

This trial is currently recruiting. It is a NA study. The enrollment target is 112 participants. The study started on 2025-06-24. Estimated completion is 2028-12-31.

What conditions does trial NCT06989086 study?

This clinical trial studies the following conditions: Caregiver, Astrocytoma, Oligodendroglioma, Glioblastoma (GBM), Primary Malignant Brain Tumor.

What interventions are being tested in trial NCT06989086?

The interventions under investigation include: Fearless in Neuro-Oncology (BEHAVIORAL).

Who is sponsoring clinical trial NCT06989086?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06989086 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Caregiver

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.